Transcutaneous IL-2 uptake mediated by Transfersomes® depends on concentration and fractionated application

Cytokine

Volumn 25, Issue 4, 2004, Pages 141-146

  Hofer, Christian ^a   Van Randenborgh, Heiner ^a   Lehmer, Antonie ^a   Hartung, Rudolf ^a   Breul, Jürgen ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Immunotherapy; Interleukin 2; Renal cell cancer; Subcutaneous injection; Transdermal therapy

Indexed keywords

CHOLIC ACID; IMMUNOLIPOSOME; PHOSPHATIDYLCHOLINE; RECOMBINANT INTERLEUKIN 2; TRANSFERSOME; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG UPTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FILTRATION; FRACTIONATION; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL;

CHIRON;

EID: 0842324782     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.10.010     Document Type: Article

References (19)

1. Cevc G., Schätzlein A., Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Release. 36:1995;3-16.
2. Paul A., Cevc G., Bachhawat B.K. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur J Immunol. 25:1995;3521-3524.
3. Hofer C., Göbel R., Deering P., Lehmer A., Breul J. Formulation of interleukin-2 and interferon-alpha containing ultradeformable carriers for potential transdermal application. Anticancer Res. 19:1999;1505-1507.
4. Hofer C., Göbel R., Deering P., Lehmer A., Breul J. Formulation of interleukin-2 and interferon-a containing ultradeformable carriers for potential transdermal application. World J Surg. 24:2000;1187-1189.
5. Salup R.R., Timot C.B., Wiltrout R.H. Successful treatment of advanced murine renal cell cancer by bicompartmental adoptive chemoimmunotherapy. J Immunol. 138:1987;641-647.
6. Planas M.E., Gonzales P., Rodriguez L., Sanchez S., Cevc G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anaesthetic liposomes. Anesth Analg. 175:1992;615-621.
7. Paul A., Cevc G. Noninvasive administration of protein antigens: transdermal immunization with bovine serum albumin in Transfersomes. Vaccine Res. 4:1995;145-151.
8. Paul A., Cevc G., Bachhawat B.K. Transdermal immunisation with an integral membrane protein, by means of ultradeformable drug carriers, transfersomes. Vaccine. 16:1998;188-195.
9. Cevc G., Gebauer D., Stieber J., Schätzlein A., Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1368:1998;201-215.
10. Cevc G., Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta. 1514:2001;191-205.
11. Ten R.M., Anderson P.M., Zein N.N., Temesgen Z., Clawson M.L., Weiss W. Interleukin-2 liposomes for primary immune deficiency using the aerosol route. Int Immunopharmacol. 2:(2-3):2002;333-344.
12. Boni L.T., Batenjany M.M., Neville M.E., Guo Y., Xu L., Wu F., et al. Interleukin-2-induced small unilamellar vesicle coalescence. Biochim Biophys Acta. 1541:(1):2001;127-138.
13. Khanna C., Anderson P.M., Hasz D.E., Katsanis E., Neville M., Klausner J.S. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer. 79:(7):1997;1409-1421.
14. Koppenhagen F.J., Visser A.J., Herron J.N., Storm G., Crommelin D.J. Interaction of recombinant interleukin-2 with liposomal bilayers. J Pharm Sci. 87:(6):1997;707-714.
15. Bergers J.J., Ben Otter W., Dullens H.F., Kerkvliet C.T., Crommelin D.J. Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines. Pharm Res. 10:(12):1993;1715-1721.
16. Anderson P.M., Hanson D.C., Hasz D.E., Halet D.E., Blazar B.R., Ochoa A.C. Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSR and interferon-gamma. Cytokine. 6:(1):1994;92-101.
17. Kedar E., Braun E., Rutkowski Y., Emanuel N., Barenholz Y. Delivery of cytokines by liposomes II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice . Immunother Emphasis Tumor Immunol. 16:(2):1994;115-124.
18. Neville M.E., Boni L.T., Pflug L.E., Popescu M.C., Robb R.J. Biopharmaceutics of liposomal interleukin 2, oncolipin. Cytokine. 12:(11):2000;1691-1701.
19. Kanaoka E., Takahashi K., Yoshikawa T., Jizomoto H., Nishihara Y., Hirano K.A. Novel and simple type of liposome carrier for recombinant interleukin-2. J Pharm Pharmacol. 53:(3):2001;295-302.